Indatuximab ELISA Kit

SKU:BHE21400296
Overview
Click light‑blue chips for details
Indatuximab ELISA Kit is a quantitative colorimetric ELISA for measuring Indatuximab levels in plasma, serum. The assay covers a 0.31-5 μg/mL standard-curve range, detects down to 0.156 μg/mL, with typical spike recovery of 80-120%, supporting reproducible standard-curve quantification across experimental conditions.
Assay Type Quantitative Colorimetric ELISA
Sample Type Plasma, Serum
Sensitivity 0.156 μg/mL
Detection Range 0.31-5 μg/mL
Plate Format 96-well (96T)
Options selector
Catalog no. Size
DB943018-96T 96 T
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: Size: 96 T
  • Lead time: options listed in "Availability Content"; other statuses may take longer.
  • Storage: The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
  • Shipping: 2-8 °C
  • Upon receipt: refrigerate upon receipt.
  • Sales terms and conditions: Please review prior to ordering.
Field Specification
Target Indatuximab
Alternative names BT-062, nBT062-DM4, Indatuximab ravtansine
UniProt # P18827
CAS no. 1238517-16-2
Reactivity
  • Human
Applications
  • ELISA
Assay type
  • Quantitative
Sample type(s) Plasma, Serum
Sensitivity 0.156 μg/mL
Detection range 0.31-5 μg/mL
Detection method
  • Colorimetric
Storage The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Shipping 2-8 ℃
Catalog no. (Mfr.) DB943018
Main SKU BHE21400296
Therapeutic Drug Monitoring

Assay Principle

Indatuximab ELISA Kit is a quantitative colorimetric ELISA designed to measure Indatuximab in research samples. Concentrations are interpolated from a standard curve, giving traceable quantitative readouts for comparative analyses across experimental conditions.

Background

Indatuximab ravtansine (BT062) is an antibody-drug conjugate (ADC) based on a murine/human chimeric form of B-B4 (CD138-specific antibody), which is covalently conjugated to the maytansinoid drug DM4 via a disulfide bond-based linker. Maytansinoids are structural analogs of the cytotoxic agent maytansine, which has been evaluated in phase I and phase II clinical trials. They exhibit anti-mitotic activity by inducing metaphase arrest of dividing cells, causing cell death. Upon internalization of indatuximab ravtansine by target tumor cells, lysosomal processing of the disulfide linker generates a lysine metabolite which is reduced and S-methylated producing the lipophilic and cytotoxic metabolite, S-methyl-DM4. The mechanism of action of indatuximab ravtansine resembles that of trastuzumab emtansine, an antibody-drug conjugate indicated for HER2-positive metastatic breast cancer which uses the HER2-targeting properties of trastuzumab to deliver the cytotoxic DM1 within the cell by means of a stable linker. The intracellular drug delivery to target tumor cells can improve the therapeutic index of the cytotoxic drug and minimize exposure of normal tissue. Indatuximab ravtansine has previously been shown in vivo in multiple myeloma mouse xenograft models to significantly inhibit tumor growth and prolong host survival without any toxicity signals. Based on these preclinical results, a phase I clinical trial of indatuximab ravtansine demonstrated the first signs of clinical activity in patients with relapsed or refractory multiple myeloma without any toxicity signals. Furthermore, preliminary data from a phase I/IIa study in relapsed or refractory multiple myeloma indicated that indatuximab ravtansine is well tolerated even in a multiple-dose schedule and provided further evidence of clinical activity. Indatuximab ravtansine is being investigated as part of a treatment for multiple myeloma.

Specifications

Assay Type Quantitative Colorimetric ELISA
Detection Method Colorimetric
Plate Format 96-well (96T)
Sample Types Plasma, Serum
Sensitivity 0.156 μg/mL
Detection Range 0.31-5 μg/mL
Recovery 80-120%
Stability & Storage The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Shipping 2-8 °C
CAS Number 1238517-16-2
UniProt P18827
Alternative Names BT-062, nBT062-DM4, Indatuximab ravtansine

Performance Data

The kit provides a quantitative range of 0.31-5 μg/mL, an analytical sensitivity of 0.156 μg/mL, typical spike recovery of 80-120%. Plan sample dilutions so readouts fall within the linear portion of the standard curve, and evaluate matrix effects with dilution-linearity and spike-recovery controls.

Target Notes

The target is also referenced in the literature as BT-062, nBT062-DM4, Indatuximab ravtansine. Curated target information is available under UniProt accession P18827. The corresponding compound is registered under CAS 1238517-16-2.

Common Research Applications

  • Pharmacokinetic profiling of the drug in preclinical and translational research models
  • Bioanalytical method development, bridging, and comparability studies
  • Stability and formulation studies requiring reproducible concentration readouts

Safety & Handling

For Research Use Only. Not for diagnostic or therapeutic use. Handle all reagents and samples according to your institution's laboratory safety guidelines, and store components as recommended to preserve assay performance.

Q.Which sample types are compatible with this kit?
A.The kit is validated for Plasma, Serum. For other matrices, evaluate dilution linearity and spike recovery before routine use.
Q.What is the detection limit?
A.The analytical sensitivity is 0.156 μg/mL. Samples near the detection limit should be run with replicates for reliable interpretation.
Q.What is the quantitative range?
A.The standard curve covers 0.31-5 μg/mL. Dilute concentrated samples so readings fall within this range.
Q.How should the kit be stored?
A.The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Q.How is the kit shipped?
A.The kit ships at 2-8 °C. Refrigerate upon receipt and follow the datasheet for component-level storage.
Q.Is this kit for diagnostic use?
A.No. This product is For Research Use Only (RUO) and is not intended for diagnostic or therapeutic procedures.

Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today